COVID-19: DHA approves 10-week interval between two doses of Oxford vaccine
Dubai Well being Authority (DHA) has accredited a ten-week interval between the primary and second dose of the Oxford-AstraZeneca vaccine. DHA mentioned this was primarily based on current research from the College of Oxford on the Oxford-AstraZeneca vaccine and as per the suggestions of the World Well being Organisation (WHO).
In a tweet printed on its official web page, the authority mentioned: “Current research from the College of Oxford on the Oxford-AstraZeneca vaccine confirmed a better effectivity and better acquired immunity when the dosing interval between the primary and second dose was elevated. Primarily based on current research from the College of Oxford on the Oxford-AstraZeneca vaccine and as per the suggestions of WHO, DHA has accredited a ten-week interval between the primary and second dose of the Oxford-AstraZeneca vaccine.”
All those that are due for the second dose of this vaccine will obtain a textual content message with the date and placement for his or her vaccination appointment, the authority mentioned.
The transfer comes at a time when the UAE remains to be reporting 3,000-plus COVID-19 circumstances every day. Simply right this moment, the Ministry of Well being and Prevention (MoHAP) introduced 16 deaths and three,498 new coronavirus circumstances, taking the overall variety of confirmed an infection within the nation to 385,160 and fatalities to 1,198.
Additionally right this moment, Dubai’s Supreme Committee for Disaster and Catastrophe Administration, headed by Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, introduced that the COVID-19 precautionary measures launched at first of February shall be prolonged till the beginning of Ramadan in mid-April. The choice was primarily based on an analysis of the evolving COVID-19 scenario and with knowledge supporting the effectiveness of intensified security measures and the suggestions of frontline authorities.